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Objective: Renal resistive index (RRI) varies directly with renal vascular stiffness
and pulse pressure. RRI correlates positively with arteriolosclerosis in damaged
kidneys and predicts progressive renal dysfunction. Matrix Gla-protein (MGP) is
a vascular calciﬁcation inhibitor that needs vitamin K to be activated. Inactive
MGP, knownas desphospho-uncarboxylatedMGP(dp-ucMGP), canbemeasured in
plasma and has been associated with various cardiovascular (CV) markers, CV out-
comes and mortality. In this study we hypothesize that increased RRI is associated
with high levels of dp-ucMGP.
Design and method: We recruited participants via a multi-center family-based
cross-sectional study in Switzerland exploring the role of genes and kidney hemody-
namics in blood pressure regulation. Dp-ucMGP was quantiﬁed in plasma samples
by sandwichELISA.Renal doppler sonographywas performed using a standardized
protocol to measure RRIs on 3 segmental arteries in each kidney. The mean of the
6 measures was reported. Multiple regression analysis was performed to estimate
associations between RRI and dp-ucMGP adjusting for sex, age, pulse pressure,
mean pressure, renal function and other CV risk factors.
Results: We included 1035 participants in our analyses. Mean values were
0.64± 0.06 for RRI and 0.44± 0.21 (nmol/L) for dp-ucMGP. RRI was positively
associatedwith dp-ucMGP both before and after adjustment for sex, age, bodymass
index, pulse pressure, mean pressure, heart rate, renal function, low and high den-
sity lipoprotein, smoking status, diabetes, blood pressure and cholesterol lowering
drugs, and history of CV disease (P < 0.001).
Conclusions: RRI is independently and positively associated with high levels of
dp-ucMGP after adjustment for pulse pressure and commonCV risk factors. Further
studies are needed to determine if vitamin K supplementation can have a positive
effect on renal vascular stiffness and kidney function.
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Objective: Recent studies suggest that enlarged aortic root diameter (ARD) may
predict cardiovascular events in absence of aneurysmatic alterations. Little is known
about the inﬂuence of renal function on ARD. Our study was aimed to assess the
relationships between glomerular ﬁltration rate (GFR) and ARD in hypertensive
subjects.
Design and method:We enrolled 611 hypertensive individuals (mean age: 52± 15
years; men 63%) consecutively attending our outpatient unit of Nephrology and
Hypertension. Patients on dialysis treatment, with valvulopathy more than mild,
bicuspid aortic valve, previous cardiovascular events and genetic aortic diseases
were excluded. All the subjects underwent echocardiography. ARD was measured
at the level of Valsalva’s sinuses by M-mode tracings, under two-dimensional con-
trol. In line with the PAMELA study, ARD, ARD indexed to body surface area
(ARD/BSA) and to height (ARD/H)were considered increasedwhen they exceeded
3.8 cm, 2.1 cm/m2, 2.3 cm/m in men and 3.4 cm, 2.2 cm/m2, 2.2 cm/m in women,
respectively. GFR was estimated by the CKD-EPI equation. The study popula-
tion was categorized in seven groups: subjects without chronic kidney disease (no
CKD) and subjects with increasing severity of CKD (1, 2, 3a, 3b, 4, 5), according
to KDIGO classiﬁcation.
Results: Estimated GFR (eGFR) was lower in subjects with values of ARD,
ARD/BSAandARD/H above the sex-speciﬁc cut-offswhen compared to thosewith
normal aortic root size (all p < 0.001). The analysis of the distribution ARD/BSA
in subjects with and in those without CKD, showed a progressive increase of
ARD/BSA from the group with normal renal function to the groups with greater
severity of CKD (ﬁgure).
eGFR correlated signiﬁcantly with ARD (r = - 0.17), ARD/BSA (r = - 0.43) and
ARD/H (r = - 0.40; all p < 0.001). The associations of eGFR with ARD/BSA (=
- 0.23) and ARD/H (= - 0.17; all p < 0.001) held in linear multiple regression
analyses, after adjustment for various confounding factors.
No CKD
1.00
A
or
ti
c 
ro
ot
 d
ia
m
et
er
/B
S
A
,c
m
/m
2
1.20
1.40
1.60
1.80
2.00
2.20
2.40
1 2
Stages of chronic kidney disease (CKD)
3a 3b 3 5
Conclusions: Our study seems to suggest that a reduced renal function may
adversely inﬂuence ARD. This may contribute to explain the enhanced cardio-
vascular risk associated with renal insufﬁciency.
1D.05 AORTIC-BRACHIAL STIFFNESS MISMATCH INPRE-DIALYSIS CHRONIC KIDNEY DISEASE
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Objective: The loss of physiological stiffness mismatch between aorta and periph-
eral arteries was strongly and independently associated with increased mortality in
adult dialysis population. The aim of the study was to evaluate if the reversal of
arterial stiffness mismatch was present in pre-dialysis patients with chronic kidney
disease (CKD).
Design and method: The aortic-brachial arterial stiffness mismatch (pulse wave
velocity (PWV ratio) were assessed using carotid-femoral PWV divided by
carotid-radial PWV in 112 adult treated hypertensive CKD patients: 54 - with
CKD IIIa (age 59,5± 8,4 years, male 46,3%, brachial blood pressure (BP)
149,6± 10,3/85,8± 9,8 mmHg), 35 - with CKD IIIb (age 60,2± 7,8 years, male
45,7%,BP 152,5± 12,5/86,4± 10,2mmHg) and 23with CKD IV (age 57,3± 10,2,
male 43,4%, BP 156,1± 14,3/92,8± 12,4 mmHg). P < 0,05 was considered signif-
icant for group comparisons, Spearman correlation test and multivariate regression
analysis.
Results: InCKD IIIa aortic PWVwas 10,2± 2,0m/s, brachial PWV12,9± 1,6m/s,
PWV ratio 0,82± 0,25. In CKD IIIb aortic PWVwas 11,3± 2,9m/s, brachial PWV
12,2± 1,8m/s, PWV ratio 0,90± 0,27. In CKD IV aortic PWV was 12,7± 3,1m/s
(p < 0,05 vs CKD IIIa), brachial PWV 11,4± 1,6m/s (p < 0,05 vs CKD IIIa),
PWV ratio 1,09± 0,33 (p < 0,05 vs CKD IIIa). Increased aortic stiffness (aortic
PWV>10m/s) was observed in 55,6%, 62,9% and 73,9%, respectively. For the
whole study population (n = 112) multivariate analysis revealed independent signif-
icant correlation between aortic PWV and glomerular ﬁltration rate (GFR) =-0,36
(p < 0,05), PWV ratio and GFR =-0,32 (p < 0,05), PWV ratio and age =0,44
(p < 0,05).
Conclusions: In the pre-dialysis hypertensive CKD patients worsening of kid-
ney function was associated with discordant changes in aortic and brachial artery
stiffness in the reversal of the physiological stiffness mismatch. The loss of this
physiological mismatch may promote kidney damage through increased forward
pressure wave transmission into the microcirculation. PWV ratio evaluation (in
addition to traditional aortic PWVmeasurement)may be useful for better evaluation
of arterial stiffness in pre-dialysis CKD patients.
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